Navigation Links
Logical Therapeutics to Present Data on LT-NS001 at American College of Gastroenterology Annual Meeting
Date:10/20/2009

ile among all of the drugs in this class.

In this study, subjects underwent upper endoscopies at baseline and on day seven. Subjects receiving LT-NS001 experienced significantly fewer endoscopically-confirmed gastric ulcers compared to subjects receiving naproxen. The full results from this study will be presented at the American College of Gastroenterology meeting on October 27 in San Diego, Calif.

"In the U.S. alone, the direct costs of treating ulcer complications associated with NSAID use exceed $4 billion annually, and serious complications such as hemorrhage and perforation are directly responsible for approximately 20,000 deaths per year," Lankau said. "LT-NS001 has the potential to help bring down these costs and reduce serious complications for patients whose need for NSAID anti-inflammatory treatment is complicated by significant gastrointestinal risks."

About Logical Therapeutics Inc.

Based in Waltham, MA, Logical Therapeutics, Inc. is a venture-backed, privately held biotechnology company focused on the development of products that treat diseases associated with inflammation. Logical's investors include SV Life Sciences, Burrill and Company, Novo Ventures A/S, and Novitas Capital. For more information on Logical Therapeutics, visit the company's website at www.logicaltx.com.

Please address inquiries regarding LT-NS001 to Logical Therapeutics' business development department at bd@logicaltx.com.

SOURCE Logical Therapeutics, Inc.


'/>"/>
SOURCE Logical Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma
2. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
3. Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health (CDRH)
4. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
5. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
6. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
7. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
8. Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
9. Study Shows How Defective DNA Repair Triggers Two Neurological Diseases
10. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
11. The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Countrys Biological Preparedness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , , LYON, France, Nov. 19 ...tes supplying dangerous and illegal medicines, Ope...dinated by INTERPOL and the World Health Organizat...eiting Taskforce (IMPACT) to highlight the dangers...lobal initiative resulted in a series of arrests a...
(Date:11/19/2009)... , , ABBOTT PARK, Ill., Nov. 19 /PRNewswi... Abbott (NYSE: ABT ) as one of its Most Admired ...ar. The Deal honored Abbott as its Most Admired...e strategic use of acquisitions and divestitures s...ott has reshaped its business portfolio with a foc...
(Date:11/19/2009)... , , NEWPORT NEWS, Va., Nov. 19 /PRNewswir...st Imaging (BSGI/MBI) has been recognized and endo...fight against breast cancer: The Society of Breast...s. Both societies published articles supporting th... technology for the early detection of breast canc...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3EPIX Pharmaceuticals Inc Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered F 55886 1EPIX Pharmaceuticals Inc Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered F 55886 2Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 1Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 2Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 3Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 4GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 1GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 2GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 3GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 4
(Date:11/22/2009)..., WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -...wing statement upon the United States Senate,s vot...h Care legislation: ,, "Senators Arlen Specter ... and all Pennsylvanians for casting stand-up, crit...nt Obama,s historic Affordable Health Care Reform ...
(Date:11/21/2009)... , NEW YORK, Nov. 21 Milvia Lo...ew York City, recently filed suit, in Supreme Cour...he complaint alleges that while Ms. Lopez underwen... at ST. VINCENT,S HOSPITAL , doctors used an HIV ...mplaint alleges that several hours after being dis...
(Date:11/21/2009)... NH based medical credentialin...in its industry to form a partnerhsip with Amerine... This partnership will help to transform quality ... (Vocus) November 21, 2009 -- ISG Group...nounced a new agreement with Amerinet Inc., a lead...
(Date:11/21/2009)... New Haven Dental Group merges...D.S of Branford, CT. , (P...oup, comprised of partners Dr. David Gibson, Dr. D...rrester has just merged their growing practice wit...., , ,When Dr. Pickman decided he wanted to retire...
(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNewswire...ng senators to modify health care reform legislati... regarding a health insurance individual coverage ...enforceable mandate will minimize adverse selectio...rules prescribed by the bill. ,, "The individua...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2
... , , Nation,s largest network of Hispanic healt...ealth care reform in 2009 , , WASHINGTON, March 5...ove access for the underinsured, and make sure tha...nce for Hispanic Health, the nation,s leading Hisp...
... Urges LCA-Vision Stockholders to Vote the GOLD Ca...aq: LCAV ) announces that RiskMetrics Group,s IS...ion stockholders vote to retain the Company,s curr...oup,s consent solicitation. After in-person meeti...
... Dr. Steven St. Peter Named to Proteon Board of Di...l, one of the world,s largest life sciences-dedica...t it is the lead investor in a $38 million Series ...utics Board of Directors. , , Proteon recently i...
... HILLSBOROUGH, Calif., March 5 Apex Bioventures A...Apex") announced today that its board of directors...siness combination in the time frame required by i...te until a plan of liquidation is approved by the ...
...ut insights into how that happens may lead to ways... March 5 (HealthDay News) -- Temozolomide, a stand...essiveness of surviving cancer cells, making tumor...s in brain tumors called gliomas that have stem ce...
... MAYWOOD, Il. -- When Joyce Moss recently arrived...ning heart attack, it took just 42 minutes to perf...dure opened up an artery that was 100 percent bloc...ngioplasty times, Loyola will become the first hos...
Other Medicine News:Health News:Alliance President and CEO Dr. Jane L. Delgado Joins President Obama at White House to Launch Health Reform Agenda 2Health News:Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group 2Health News:Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group 3Health News:MPM Capital Leads Investment in Proteon Therapeutics 2Health News:Apex Bioventures Acquisition Corp. To Seek Stockholder Approval To Liquidate and Dissolve 2Health News:Brain Tumor Drug May Help Spur Cancer's Return 2Health News:Brain Tumor Drug May Help Spur Cancer's Return 3Health News:Saving heart attack patients in the middle of the night 2Health News:Saving heart attack patients in the middle of the night 3Health News:Saving heart attack patients in the middle of the night 4
AVOXimeter 1000E
RF CONDUCTR (MC)
...s examined with an ocular fundus image displayed o...ge and the perimetry result, you can grasp the cor...ates with Kowa VK2 Digital imaging system enabling... perimetry results, and ensure smooth fundus image...
SkinStation Phototherapy System
Medicine Products: